Crestal Bone Level After Allogenic Bone Ring With Simultaneous Dental Implant Placement

Evaluation Of Crestal Bone Level After Alveolar Bone Augmentation of Atrophied Posterior Mandibular Region Using Allogenic Bone Rings Vs. Autogenous Bone Rings With Simultaneous Dental Implant Placement (A Randomized Controlled Clinical Trial)

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03906591

Enrollment

Registered

2019-04-08

Start date

2019-10-31

Completion date

2023-02-28

Last updated

2019-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allogenic Bone Ring

Brief summary

This trial is aiming to answer a question whether in Patients with severely atrophied, distal mandibular regions, the use of allogenic bone rings with simultaneous dental implants, compared to autogenous bone rings, give successful clinical and radiographic outcomes without donor site morbidity

Interventions

PROCEDUREallogenic bone ring

allogenic bone ring with simultaneous dental implant placement

PROCEDUREautogenous bone ring

autogenous bone ring with simultaneous dental implant placement

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to 60 Years

Healthy volunteers

Yes

Inclusion criteria

1. Medically free form any systemic diseases that contraindicate the surgical procedures or affect predictable outcomes and non-smoker subjects. 2. Atrophic mandibular distal region requiring vertical augmentation. 3. Good oral hygiene and healthy keratinized mucosa.

Exclusion criteria

1. Presence of acute dentoalveolar infection or any pathologic lesions. 2. Totally edentulous patients and patients requiring massive reconstruction and augmentation procedures. 3. Patients with history of previously failed augmentation procedures, or failed implant placement at the intended augmentation region.

Design outcomes

Primary

Measure	Time frame	Description
change in crestal bone height	at 6 months	cone beam computed tomography will be used to measure bone height in millimeters

Secondary

Measure	Time frame	Description
graft failure	after 1 week, 6 months and after 9 months	signs of graft failure will be evaluated by clinical examination
implant loss	after 1 week, 6 months and after 9 months	signs of implant loss will be evaluated by clinical examination

Contacts

Primary Contactalaa ragab, master

dralaa3@hotmail.com00201224665688

Backup ContactSherif Aly, PhD

Sherief.ali@hotmail.com00201001932020

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026